PMS30 Pharmacoeconomic Evaluation of Tocilizumab Monotherapy Versus Adalimumab Monotherapy in Reducing Disease Activity in Patients With Rheumatoid Arthritis
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.1385
https://www.valueinhealthjournal.com/article/S1098-3015(12)03098-7/fulltext
Title :
PMS30 Pharmacoeconomic Evaluation of Tocilizumab Monotherapy Versus Adalimumab Monotherapy in Reducing Disease Activity in Patients With Rheumatoid Arthritis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03098-7&doi=10.1016/j.jval.2012.08.1385
First page :
A444
Section Title :
Muscular-Skeletal Disorders
Open access? :
No
Section Order :
883